2月2日,观合医药全资子公司无锡观合医学检验所有限公司顺利通过美国病理学家协会(College of American Pathologists,CAP)现场复评审认可。这是观合医药集团第10次获得CAP认可,也是无锡观合第3次通过该项评审,标志着实验室在质量管理体系、检测技术水平以及规范化运营等方面,持续与全球最高质量标准接轨,检测结果可实现国际互认,为全球临床试验(MRCT)及注册申报提供严谨...
Source Link2月2日,观合医药全资子公司无锡观合医学检验所有限公司顺利通过美国病理学家协会(College of American Pathologists,CAP)现场复评审认可。这是观合医药集团第10次获得CAP认可,也是无锡观合第3次通过该项评审,标志着实验室在质量管理体系、检测技术水平以及规范化运营等方面,持续与全球最高质量标准接轨,检测结果可实现国际互认,为全球临床试验(MRCT)及注册申报提供严谨...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.